Medicenna Therapeutics (MDNA) Competitors C$1.71 +0.03 (+1.79%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades MDNA vs. DNA, VBV, CUS, AIM, FRX, APM, IPA, ITH, CRDL, and GXEShould you be buying Medicenna Therapeutics stock or one of its competitors? The main competitors of Medicenna Therapeutics include Dalradian Resources (DNA), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Fennec Pharmaceuticals (FRX), Andean Precious Metals (APM), ImmunoPrecise Antibodies (IPA), International Tower Hill Mines (ITH), Cardiol Therapeutics (CRDL), and Gear Energy (GXE). These companies are all part of the "pharmaceutical products" industry. Medicenna Therapeutics vs. Dalradian Resources VBI Vaccines Chemtrade Electrochem Inc, Aimia Fennec Pharmaceuticals Andean Precious Metals ImmunoPrecise Antibodies International Tower Hill Mines Cardiol Therapeutics Gear Energy Dalradian Resources (TSE:DNA) and Medicenna Therapeutics (TSE:MDNA) are both small-cap basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, analyst recommendations, earnings and institutional ownership. Do insiders & institutionals believe in DNA or MDNA? 13.0% of Medicenna Therapeutics shares are held by institutional investors. 22.6% of Medicenna Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor DNA or MDNA? In the previous week, Dalradian Resources' average media sentiment score of 0.00 equaled Medicenna Therapeutics'average media sentiment score. Company Overall Sentiment Dalradian Resources Neutral Medicenna Therapeutics Neutral Is DNA or MDNA more profitable? Dalradian Resources' return on equity of 0.00% beat Medicenna Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Dalradian ResourcesN/A N/A N/A Medicenna Therapeutics N/A -105.43%-32.80% Does the MarketBeat Community favor DNA or MDNA? Dalradian Resources received 117 more outperform votes than Medicenna Therapeutics when rated by MarketBeat users. However, 68.22% of users gave Medicenna Therapeutics an outperform vote while only 66.78% of users gave Dalradian Resources an outperform vote. CompanyUnderperformOutperformDalradian ResourcesOutperform Votes20566.78% Underperform Votes10233.22% Medicenna TherapeuticsOutperform Votes8868.22% Underperform Votes4131.78% Which has preferable valuation & earnings, DNA or MDNA? Medicenna Therapeutics is trading at a lower price-to-earnings ratio than Dalradian Resources, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDalradian ResourcesN/AN/AN/A-C$0.03N/AMedicenna TherapeuticsN/AN/A-C$26.24M-C$0.38-4.50 SummaryDalradian Resources and Medicenna Therapeutics tied by winning 4 of the 8 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Medicenna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDNA vs. The Competition Export to ExcelMetricMedicenna TherapeuticsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$130.70MC$166.07MC$5.12BC$6.05BDividend YieldN/A3.64%4.91%5.43%P/E Ratio-4.50114.6691.3426.16Price / SalesN/A17,963.611,117.701,327.99Price / Cash1.1512.7542.6482.04Price / Book5.708.404.793.07Net Income-C$26.24M-C$20.67MC$120.07MC$294.08M7 Day Performance-3.39%-1.08%-1.90%-2.47%1 Month Performance14.77%135.79%11.45%-0.78%1 Year Performance317.07%136.53%30.63%34.57% Medicenna Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDNAMedicenna TherapeuticsN/AC$1.71+1.8%N/A+317.1%C$130.70MN/A-4.5020DNADalradian ResourcesN/AC$1.46-0.7%N/AN/AC$519.02MN/A-56.15640VBVVBI VaccinesN/AC$4.82-5.1%N/AN/AC$308.86MC$3.36M-4.9722CUSChemtrade Electrochem Inc,N/AC$1.64-0.6%N/AN/AC$306.50MN/A0.0060AIMAimia2.0706 of 5 starsC$2.66-1.8%C$4.00+50.4%-18.0%C$261.69MC$396.20M-2.0020News CoverageGap DownFRXFennec PharmaceuticalsN/AC$8.51-2.0%N/A-37.9%C$232.83MC$48.89M85.1010Analyst RevisionNews CoverageAPMAndean Precious MetalsN/AC$1.32-3.6%C$1.70+28.8%N/AC$197.16MC$199.84M3.4730IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080News CoverageGap DownITHInternational Tower Hill MinesN/AC$0.69-4.2%N/A-1.5%C$137.79MN/A-23.00220Gap DownCRDLCardiol TherapeuticsN/AC$1.91+1.1%N/A+59.8%C$133.12MN/A-4.3320News CoverageGXEGear Energy2.9755 of 5 starsC$0.48flatC$1.00+108.3%-26.6%C$126.52MC$134.93M9.601,310Dividend Announcement Related Companies and Tools Related Companies Dalradian Resources Alternatives VBI Vaccines Alternatives Chemtrade Electrochem Inc, Alternatives Aimia Alternatives Fennec Pharmaceuticals Alternatives Andean Precious Metals Alternatives ImmunoPrecise Antibodies Alternatives International Tower Hill Mines Alternatives Cardiol Therapeutics Alternatives Gear Energy Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:MDNA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicenna Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicenna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
